Khan M - Search Results

1

Ingested IFN-alpha has biological effects in humans with relapsing-remitting multiple sclerosis.

Brod SA, Kerman RH, Nelson LD, Marshall GD Jr, Henninger EM, Khan M, Jin R, Wolinsky JS. Brod SA, et al. Among authors: khan m. Mult Scler. 1997 Feb;3(1):1-7. doi: 10.1177/135245859700300101. Mult Scler. 1997. PMID: 9160341 Clinical Trial.

2

Oral administration of human or murine interferon alpha suppresses relapses and modifies adoptive transfer in experimental autoimmune encephalomyelitis.

Brod SA, Khan M, Kerman RH, Pappolla M. Brod SA, et al. Among authors: khan m. J Neuroimmunol. 1995 Apr;58(1):61-9. doi: 10.1016/0165-5728(94)00188-t. J Neuroimmunol. 1995. PMID: 7537281

3

Decreased CD3-mediated interferon-gamma production in relapsing-remitting multiple sclerosis.

Brod SA, Khan M, Bright J, Sriram S, Marshall GD Jr, Henninger EM, Kerman RH, Wolinsky JS. Brod SA, et al. Among authors: khan m. Ann Neurol. 1995 Apr;37(4):546-9. doi: 10.1002/ana.410370418. Ann Neurol. 1995. PMID: 7717692

4

Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis.

Brod SA, Marshall GD Jr, Henninger EM, Sriram S, Khan M, Wolinsky JS. Brod SA, et al. Among authors: khan m. Neurology. 1996 Jun;46(6):1633-8. doi: 10.1212/wnl.46.6.1633. Neurology. 1996. PMID: 8649562

5

Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis.

Brod SA, Khan M. Brod SA, et al. Among authors: khan m. J Autoimmun. 1996 Feb;9(1):11-20. doi: 10.1006/jaut.1996.0003. J Autoimmun. 1996. PMID: 8845048

6

IFN-beta 1b treatment of relapsing multiple sclerosis has no effect on CD3-induced inflammatory or counterregulatory anti-inflammatory cytokine secretion ex vivo after nine months.

Brod SA, Nelson LD, Khan M, Wolinsky JS. Brod SA, et al. Among authors: khan m. Int J Neurosci. 1997 Jun;90(1-2):135-44. doi: 10.3109/00207459709000633. Int J Neurosci. 1997. PMID: 9285295 Clinical Trial.

7

Increased in vitro induced CD4+ and CD8+ T cell IFN-gamma and CD4+ T cell IL-10 production in stable relapsing multiple sclerosis.

Brod SA, Nelson LD, Khan M, Wolinsky JS. Brod SA, et al. Among authors: khan m. Int J Neurosci. 1997 Aug;90(3-4):187-202. doi: 10.3109/00207459709000638. Int J Neurosci. 1997. PMID: 9352427 Review.

8

Oral administration of type I interferon modulates the course of experimental allergic neuritis.

Vriesendorp FJ, Flynn RE, Khan M, Pappolla MA, Brod SA. Vriesendorp FJ, et al. Among authors: khan m. Autoimmunity. 1996;24(3):157-65. doi: 10.3109/08916939608995361. Autoimmunity. 1996. PMID: 9020408 Free article.

9

Adoptive transfer from interferon-alpha-fed mice is associated with inhibition of active experimental autoimmune encephalomyelitis by decreasing recipient tumor necrosis factor-alpha secretion.

Brod SA, Khan M, Nelson LD, Decuir B, Malone M, Henninger E. Brod SA, et al. Among authors: khan m. J Immunother. 2000 Mar-Apr;23(2):235-45. doi: 10.1097/00002371-200003000-00008. J Immunother. 2000. PMID: 10746550

10

Use of bare-mounted Palmaz-Schatz stents employing the stent saddle technique on the delivery balloon: a single center experience.

Levine G, Khan MM, Kleiman NS, Raizner AE, Jeroudi MO, Mickelson J, Ali MN. Levine G, et al. Among authors: khan mm. Cathet Cardiovasc Diagn. 1997 Aug;41(4):361-8. doi: 10.1002/(sici)1097-0304(199708)41:4<361::aid-ccd1>3.0.co;2-3. Cathet Cardiovasc Diagn. 1997. PMID: 9258473 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,074 results

Search Page

Filters